Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer
- PMID: 18457335
- PMCID: PMC2610244
- DOI: 10.1002/pon.1368
Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer
Abstract
Objective: To (1) evaluate the feasibility of touch screen depression screening in cancer patients using the Patient Health Questionnaire-9 (PHQ-9), (2) evaluate the construct validity of the PHQ-9 using the touch screen modality, and (3) examine the prevalence and severity of depression using this screening modality.
Methods: The PHQ-9 was placed in a web-based survey within a study of the clinical impact of computerized symptom and quality of life screening. Patients in medical oncology, radiation oncology, and hematopoietic stem cell transplantation (HSCT) clinics used the program on a touch screen computer in waiting rooms prior to therapy (T1) and during therapy (T2). Responses of depressed mood or anhedonia (PHQ-2 cardinal depression symptoms) triggered additional items. PHQ-9 scores were provided to the oncology team in real time.
Results: Among 342 patients enrolled, 33 (9.6%) at T1 and 69 (20.2%) at T2 triggered the full PHQ-9 by endorsing at least one cardinal symptom. Feasibility was high, with at least 97% completing the PHQ-2 and at least 96% completing the PHQ-9 when triggered and a mean completion time of about 2 min. The PHQ-9 had good construct validity. Medical oncology patients had the highest percent of positive screens (12.9%) at T1, while HSCT patients had the highest percent (30.5%) at T2. Using this method, 21 (6.1%) at T1 and 54 (15.8%) at T2 of the total sample had moderate to severe depression.
Conclusions: The PHQ-9 administered on a touch screen computer is feasible and provides valid depression data in a diverse cancer population.
(c) 2008 John Wiley & Sons, Ltd.
Similar articles
-
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial.Cancer. 2017 Feb 1;123(3):485-493. doi: 10.1002/cncr.29969. Epub 2016 Nov 10. Cancer. 2017. PMID: 27861753 Free PMC article. Clinical Trial.
-
Standardized assessment of depression symptoms in post-acute care: A screening threshold approach.J Am Geriatr Soc. 2022 Apr;70(4):1023-1034. doi: 10.1111/jgs.17646. Epub 2022 Mar 2. J Am Geriatr Soc. 2022. PMID: 35235215
-
Postpartum depression screening at well-child visits: validity of a 2-question screen and the PHQ-9.Ann Fam Med. 2009 Jan-Feb;7(1):63-70. doi: 10.1370/afm.933. Ann Fam Med. 2009. PMID: 19139451 Free PMC article.
-
Reliability and Validity of the Patient Health Questionnaire-9 as a Screening Tool for Poststroke Depression.J Neurosci Nurs. 2019 Jun;51(3):147-152. doi: 10.1097/JNN.0000000000000442. J Neurosci Nurs. 2019. PMID: 31058767 Review.
-
Physician actions following a positive PHQ-2: implications for the implementation of depression screening in family medicine practice.Fam Syst Health. 2015 Mar;33(1):18-27. doi: 10.1037/fsh0000089. Epub 2014 Dec 8. Fam Syst Health. 2015. PMID: 25485822 Review.
Cited by
-
National screening for anxiety and depression in Saudi Arabia 2022.Front Public Health. 2023 Jun 27;11:1213851. doi: 10.3389/fpubh.2023.1213851. eCollection 2023. Front Public Health. 2023. PMID: 37441650 Free PMC article.
-
A Framework for Automating Psychiatric Distress Screening in Ophthalmology Clinics Using an EHR-Derived AI Algorithm.Transl Vis Sci Technol. 2022 Oct 3;11(10):6. doi: 10.1167/tvst.11.10.6. Transl Vis Sci Technol. 2022. PMID: 36180026 Free PMC article.
-
Development of computer adaptive testing for measuring depression in patients with cancer.Sci Rep. 2022 May 17;12(1):8247. doi: 10.1038/s41598-022-12318-x. Sci Rep. 2022. PMID: 35581321 Free PMC article.
-
Delivery of a Mental Health Intervention for Chronic Pain Through an Artificial Intelligence-Enabled App (Wysa): Protocol for a Prospective Pilot Study.JMIR Res Protoc. 2022 Mar 31;11(3):e36910. doi: 10.2196/36910. JMIR Res Protoc. 2022. PMID: 35314423 Free PMC article.
-
Prevalence of depression in China during the early stage of the COVID-19 pandemic: a cross-sectional study in an online survey sample.BMJ Open. 2022 Mar 9;12(3):e056667. doi: 10.1136/bmjopen-2021-056667. BMJ Open. 2022. PMID: 35264364 Free PMC article.
References
-
- Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;(32):57–71. - PubMed
-
- Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85(3):640–650. - PubMed
-
- Badger TA, Braden CJ, Mishel MH. Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer. Oncol Nurs Forum. 2001;28(3):567–574. - PubMed
-
- Kuny S, Stassen HH. Cognitive performance in patients recovering from depression. Psychopathology. 1995;28(4):190–207. - PubMed
-
- Weitzner MA, Meyers CA, Stuebing KK, Saleeba AK. Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy. Support Care Cancer. 1997;5(3):241–248. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
